3654 results for «600»
3654 results
Complications after TAVI: Aortic Annulus Events
14 Apr 2021 – From EuroPCR 2021
Watch this session about complications during or after TAVI to study how to deal with them: balloon aortic valvuloplasty complicated by acute aortic regurgitation, severe aortic regurgitation and severely diseased thoracic aorta, bicuspid aortic valve and challenging transfemoral access, or complete heart block, and more!
CTO: imaging and devices
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, learn how to recanalize a chronic total occlusion of the right coronary artery, how IVUS can facilitate and guide PCI to ostial left circumflex CTO, how hi-tech devices are also needed in calcified artery occlusions, and even more!
CTO tools, devices and techniques
14 Apr 2021 – From EuroPCR 2021
The Capture Technique, the intra-coronary Rendezvous Technique, a new technique for proximal cap penetration in a calcified CTO... Watch this session to get all the necessary tools to handle CTO!
Challenging scenarios in STEMI patients
14 Apr 2021 – From EuroPCR 2021
In this session, you'll discover challenging STEMI cases: STEMI with cardiogenic shock and no vascular access for mechanical support, anterior STEMI with critical LMCA stenosis, double culprits STEMI, and much more!
Challenging cases in difficult clinical scenarios
14 Apr 2021 – From EuroPCR 2021
Thanks to this session, you will know more about how to manage simultaneous myocardial infarction and arm ischemia, how to facilitate antegrade wiring of tortuous RCA thanks to sub-intimal dissection and stabilisation, how to guide the way when handling a difficult graft PCI, and more!
How to tackle calcified lesions for a good outcome
14 Apr 2021 – From EuroPCR 2021
View this session if you're interested in CHIP PCI in ACS with heart failure and high bleeding risk, calcific left main stem restenosis after prior treatment with lithotripsy, calcific restenosis and tight distal narrowing, and much more!
CTO PCI in images and case examples: what is new in 2026?
07 Jul 2026
Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
